The results showed that treatment with CCR7 mAb completely abrogated the CCL19-dependent activation of STAT3 (Figure 3), indicating that CCR7's activation stimulated the phosphorylation of STAT3 in SCCHN cells. Here, STAT3 is linked to head and neck squamous cell carcinoma.